HNN3.0

Project cooperationUpdated on 23 January 2026

Connecting Disease Biology with Advanced Intervention and Next-Gen Health Solutions

Internationalization Research Manager at Centro de Investigaciones Biológicas Margarita Salas-CSIC

Madrid, Spain

About

The CIB Margarita Salas is a leading CSIC center integrating molecular and cellular biosciences with cutting‑edge biomedicine to accelerate advanced therapeutic development. Our strategic expertise spans multi‑omics, infection biology, AMR, cardiovascular disease, neurodegeneration and cancer, enabling deep mechanistic insight into complex health challenges and the implementation of innovative next-generation interventions.

We offer high‑value technological capacities—including non-animal models (NAMs), organoids, CRISPR‑based gene editing, high‑resolution imaging and advanced multi‑omics platforms—that empower consortiums to drive innovation in diagnostics, target discovery, AI-driven drug design, vaccine development, disease modelling and next‑generation therapeutics.

Positioned at the intersection of bioscience excellence and translational impact, the CIB provides robust capabilities for Horizon Europe collaborations, contributing to projects shaping the future of precision medicine, AMR solutions, advanced therapies and biomedical innovation.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

Type

  • Partner seeks Consortium/Coordinator

Organisation

Similar opportunities